M. Monogue

发表

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.

T. Jodlowski, J. Sanders, M. Monogue, 2020, JAMA.

In Vivo Efficacy of Meropenem with a Novel Non-β-Lactam–β-Lactamase Inhibitor, Nacubactam, against Gram-Negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model

C. Bissantz, D. Nicolau, S. Giovagnoli, 2018, Antimicrobial Agents and Chemotherapy.

Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.

D. Nicolau, M. Monogue, J. Kuti, 2018, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Efficacy of Humanized Cefiderocol Exposures over 72 Hours against a Diverse Group of Gram-Negative Isolates in the Neutropenic Murine Thigh Infection Model

R. Echols, D. Nicolau, M. Monogue, 2018, Antimicrobial Agents and Chemotherapy.

Efficacy of Humanized Cefiderocol Exposures over 72 Hours against a Diverse Group of Gram-Negative Isolates in the Neutropenic Murine Thigh Infection Model

R. Echols, D. Nicolau, M. Monogue, 2018, Antimicrobial Agents and Chemotherapy.

Antibacterial activity of ceftolozane/tazobactam alone and in combination with other antimicrobial agents against MDR Pseudomonas aeruginosa

D. Nicolau, M. Monogue, 2018, The Journal of antimicrobial chemotherapy.

Tedizolid vs Linezolid for the Treatment of Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients

L. Hynan, J. Sanders, M. Monogue, 2021, Open forum infectious diseases.

Pharmacokinetics and Tissue Penetration of Ceftolozane-Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers

D. Nicolau, M. Monogue, Ashley K. Shepard, 2017, Antimicrobial Agents and Chemotherapy.

In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Klebsiella pneumoniae Strains

D. Nicolau, M. Monogue, S. Stainton, 2017, Antimicrobial Agents and Chemotherapy.

In Vitro Discordance with In Vivo Activity: Humanized Exposures of Ceftazidime-Avibactam, Aztreonam, and Tigecycline Alone and in Combination against New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae in a Murine Lung Infection Model

R. Bonomo, D. Nicolau, L. Abbo, 2017, Antimicrobial Agents and Chemotherapy.

Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-Negative Bacteria in a Murine Thigh Infection Model

R. Echols, D. Nicolau, M. Monogue, 2017, Antimicrobial Agents and Chemotherapy.

Translational Efficacy of Humanized Exposures of Cefepime, Ertapenem, and Levofloxacin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Complicated Urinary Tract Infection

D. Nicolau, M. Monogue, 2017, Antimicrobial Agents and Chemotherapy.

Comparative Assessment of Tedizolid Pharmacokinetics and Tissue Penetration between Diabetic Patients with Wound Infections and Healthy Volunteers via In Vivo Microdialysis

D. Nicolau, M. Monogue, Ashley K. Shepard, 2017, Antimicrobial Agents and Chemotherapy.

Antibacterial Efficacy of Eravacycline In Vivo against Gram-Positive and Gram-Negative Organisms

Y. Hamada, D. Nicolau, M. Monogue, 2016, Antimicrobial Agents and Chemotherapy.

Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation

D. Nicolau, M. Monogue, M. Muhlebach, 2016, Antimicrobial Agents and Chemotherapy.

Humanized Exposures of a β-Lactam-β-Lactamase Inhibitor, Tazobactam, versus Non-β-Lactam-β-Lactamase Inhibitor, Avibactam, with or without Colistin, against Acinetobacter baumannii in Murine Thigh and Lung Infection Models

V. Nizet, D. Nicolau, M. Monogue, 2018, Pharmacology.

Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia.

M. Monogue, K. Eljaaly, K. Bhavan, 2018, Journal of infection and public health.

Pharmacodynamics of cefiderocol, a novel siderophore cephalosporin, in a Pseudomonas aeruginosa neutropenic murine thigh model.

Islam M. Ghazi, D. Nicolau, M. Monogue, 2017, International journal of antimicrobial agents.

Humanized Exposures of Cefiderocol, a Siderophore Cephalosporin, Display Sustained in vivo Activity against Siderophore-Resistant Pseudomonas aeruginosa

Islam M. Ghazi, D. Nicolau, M. Monogue, 2018, Pharmacology.

A case–control study evaluating the unnecessary use of intravenous broad-spectrum antibiotics in presumed sepsis and septic-shock patients in the emergency department

M. Monogue, E. Bae, Tiffeny T. Smith, 2022, Antimicrobial Stewardship & Healthcare Epidemiology.

Minimal Cerebrospinal Fluid Concentration of Miltefosine despite Therapeutic Plasma Levels during the Treatment of Amebic Encephalitis

M. Monogue, Michael Zhuo Wang, D. Cavuoti, 2019, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics-pharmacodynamics of β-lactamase inhibitors: are we missing the target?

D. Nicolau, M. Monogue, 2019, Expert review of anti-infective therapy.

Susceptible bacteria survive antibiotic treatment in the mammalian gastrointestinal tract without evolving resistance

Xiaowei Zhan, L. Hooper, Erdal Toprak, 2023, bioRxiv.

Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance

D. Nicolau, M. Monogue, J. Kuti, 2016, Expert review of clinical pharmacology.

Eravacycline Pharmacokinetics and Challenges in Defining Humanized Exposure In Vivo

D. Nicolau, M. Monogue, A. Thabit, 2016, Antimicrobial Agents and Chemotherapy.

The role of tazobactam‐based combinations for the management of infections due to extended‐spectrum β‐lactamase‐producing Enterobacterales: Insights from the Society of Infectious Diseases Pharmacists

M. Monogue, S. Aitken, E. Heil, 2021, Pharmacotherapy.

Assessment of in vivo efficacy of eravacycline against Enterobacteriaceae exhibiting various resistance mechanisms: a dose-ranging study and pharmacokinetic/pharmacodynamic analysis.

D. Nicolau, M. Monogue, A. Thabit, 2018, International journal of antimicrobial agents.

Detection of Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli with Current Automated Susceptibility Test Systems

D. Nicolau, M. Monogue, S. Brecher, 2017, Infection Control & Hospital Epidemiology.

In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli

D. Nicolau, M. Monogue, 2016, Antimicrobial Agents and Chemotherapy.

Detection of Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli with Current Automated Susceptibility Test Systems

D. Nicolau, M. Monogue, S. Brecher, 2017, Infection Control & Hospital Epidemiology.

In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Multidrug-Resistant Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model

D. Nicolau, M. Monogue, Kamilia Abdelraouf, 2019, Antimicrobial Agents and Chemotherapy.

Risk Factors for Adverse Outcomes with Outpatient Parenteral Antimicrobial Therapy

Christoph U. Lehmann, M. Monogue, J. Cutrell, 2023, medRxiv.

Ceftolozane/tazobactam heteroresistance in cystic fibrosis-related Pseudomonas aeruginosa infections

Xiaowei Zhan, D. Greenberg, Christine Pybus, 2023, JAC-antimicrobial resistance.

1222. Ceftolozane-Tazobactam Heteroresistance in Cystic Fibrosis Related Pseudomonas aeruginosa Infections

D. Greenberg, Christine Pybus, A. E. Clark, 2021, Open Forum Infectious Diseases.

Clinically undetected polyclonal heteroresistance among Pseudomonas aeruginosa isolated from cystic fibrosis respiratory specimens.

Xiaowei Zhan, D. Greenberg, Christine Pybus, 2022, The Journal of antimicrobial chemotherapy.